Locations:
Search IconSearch

Tag: inflammatory bowel diseases (IBD)

18-DDI-408-VTE-CQD
May 26, 2021/Digestive/Research

Low-Dose Aspirin for Extended VTE Prophylaxis After IBD Surgery

A cost-effective alternative to enoxaparin?

19-RHE-1388-osteoporosis-650×540
May 25, 2021/Digestive/Research

Impact of Biologics Use on Bone Loss in Patients with IBD

Results of the largest population-based study to date

Nodular anterior scleritis in a patient with Behcet’s disease
March 15, 2021/Ophthalmology

Recognizing Noninfectious Autoimmune Scleritis

What to look for and when to use immunosuppressive medications

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

TNF alpha with infliximab fab fragment from NCBI
May 22, 2020/Digestive/Research

TARGET-IBD Findings Demonstrate Need for Objective Evaluation Prior to Therapy Changes

Too few patients assessed before undergoing biologic dose changes

GI system
August 15, 2019/Digestive/Research

Gastrointestinal Research Roundup: Our Latest Findings in IBD, Barrett’s Esophagus

A quick review of several advances in risk assessment and treatment

18-DDI-161-Ileal-Pouch-Feat
June 5, 2019/Digestive/Surgery

Timing of Post-IPAA Complications Predicts Long-Term Outcomes

Conditional survival study finds pouch survival improves over time

Gastroparesis Clinic-690×380

How We Improve Conditions for Complex Cases, from Gastroparesis to IBD

Innovative Cleveland Clinic programs reduce fragmentation of care

BackPage 3 of 4Next

Advertisement

Ad